These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24618888)

  • 41. Ethical aspects of the Revised National Tuberculosis Control Programme.
    Nair SS
    Indian J Med Ethics; 2011; 8(2):102-6. PubMed ID: 22106620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A cross-sectional study of tuberculosis drug resistance among previously treated patients in a tertiary hospital in Accra, Ghana: public health implications of standardized regimens.
    Forson A; Kwara A; Kudzawu S; Omari M; Otu J; Gehre F; de Jong B; Antonio M
    BMC Infect Dis; 2018 Apr; 18(1):149. PubMed ID: 29606091
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
    Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug-resistant tuberculosis in Yangon, Myanmar.
    Phyu S; Lwin T; Ti T; Maung W; Mar WW; Shein SS; Grewal HM
    Scand J Infect Dis; 2005; 37(11-12):846-51. PubMed ID: 16308219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana.
    Tembo BP; Malangu NG
    BMC Infect Dis; 2019 Sep; 19(1):779. PubMed ID: 31492099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.
    Ezati N; Lukoye D; Wampande EM; Musisi K; Kasule GW; Cobelens FG; Kateete DP; Joloba ML
    BMC Infect Dis; 2014 Dec; 14():703. PubMed ID: 25523472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study.
    Gadoev J; Asadov D; Tillashaykhov M; Tayler-Smith K; Isaakidis P; Dadu A; de Colombani P; Gudmund Hinderaker S; Parpieva N; Ulmasova D; Jalolov A; Hamraev A; Ali E; Boom Mv; Hammerich A; Gozalov O; Dara M
    PLoS One; 2015; 10(6):e0128907. PubMed ID: 26075615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antitubercular drug resistance in four healthcare facilities in North India.
    Gupta A; Mathuria JP; Singh SK; Gulati AK; Anupurba S
    J Health Popul Nutr; 2011 Dec; 29(6):583-92. PubMed ID: 22283032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru.
    Chavez Pachas AM; Blank R; Smith Fawzi MC; Bayona J; Becerra MC; Mitnick CD
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):52-8. PubMed ID: 14974746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa.
    Kigozi G; Heunis C; Chikobvu P; Botha S; van Rensburg D
    Int J Infect Dis; 2017 Jan; 54():95-102. PubMed ID: 27894985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristics and programme-defined treatment outcomes among childhood tuberculosis (TB) patients under the national TB programme in Delhi.
    Satyanarayana S; Shivashankar R; Vashist RP; Chauhan LS; Chadha SS; Dewan PK; Wares F; Sahu S; Singh V; Wilson NC; Harries AD
    PLoS One; 2010 Oct; 5(10):e13338. PubMed ID: 20967279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tuberculosis in the Circumpolar Region, 2006-2012.
    Bourgeois AC; Zulz T; Bruce MG; Stenz F; Koch A; Parkinson A; Hennessy T; Cooper M; Newberry C; Randell E; Proulx JF; Hanley BE; Soini H; Arnesen TM; Mariandyshev A; Jonsson J; Søborg B; Wolfe J; Balancev G; Bruun de Neergaard R; Archibald CP
    Int J Tuberc Lung Dis; 2018 Jun; 22(6):641-648. PubMed ID: 29862948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda.
    Kirirabwa NS; Kimuli D; DeJene S; Nanziri C; Birabwa E; Okello DA; Suarez PG; Kasozi S; Byaruhanga R; Lukoye D
    PLoS One; 2018; 13(12):e0208390. PubMed ID: 30566486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].
    Sezen F; Albayrak N; Özkara Ş; Karagöz A; Alp A; Duyar Ağca F; İnan Süer A; Müderris T; Ceyhan İ; Durmaz R; Ertek M;
    Mikrobiyol Bul; 2015 Apr; 49(2):143-55. PubMed ID: 26167815
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tuberculosis in Calgary, Canada, 1995-2002: site of disease and drug susceptibility.
    Yang H; Field SK; Fisher DA; Cowie RL
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):288-93. PubMed ID: 15786892
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK.
    Melzer M; Gupta N; Petersen I; Cook S; Hall B
    Int J Infect Dis; 2010 Aug; 14(8):e717-22. PubMed ID: 20542460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does Alcohol consumption during multidrug-resistant tuberculosis treatment affect outcome?. A population-based study in Kerala, India.
    Duraisamy K; Mrithyunjayan S; Ghosh S; Nair SA; Balakrishnan S; Subramoniapillai J; Oeltmann JE; Moonan PK; Kumar AM
    Ann Am Thorac Soc; 2014 Jun; 11(5):712-8. PubMed ID: 24735096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.
    Aparna SB; Reddy VC; Gokhale S; Moorthy KV
    Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):564-70. PubMed ID: 19243801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.
    Al-Hajoj S; Varghese B; Shoukri MM; Al-Omari R; Al-Herbwai M; Alrabiah F; Alrajhi AA; Abuljadayel N; Al-Thawadi S; Zumla A; Zignol M; Raviglione MC; Memish Z
    Antimicrob Agents Chemother; 2013 May; 57(5):2161-6. PubMed ID: 23459478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.